Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

DeJarnette Research Systems received notification from the USPTO that a patent is to be granted covering the company’s dyseCT.  

DeJarnette Research Systems , Inc. (Towson, MD) announces that it has received notification from the USPTO that a patent is to be granted covering the company’s innovative crosssectional modality QC station, dyseCT. dyseCT is the only product in the market today that provides for automated segmentation of MDCT studies into the constituent RIS orders making up the imaging study.

Source: DeJarnette Research Systems